Allan Balmain - Publications

Affiliations: 
Biochemistry and Molecular Biology University of California, San Francisco, San Francisco, CA 
Area:
Molecular Biology, Cell Biology, Biochemistry, Oncology
Website:
https://humangenetics.ucsf.edu/balmain-allan/

164/260 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Reeves MQ, Balmain A. Mutations, Bottlenecks, and Clonal Sweeps: How Environmental Carcinogens and Genomic Changes Shape Clonal Evolution during Tumor Progression. Cold Spring Harbor Perspectives in Medicine. PMID 38052482 DOI: 10.1101/cshperspect.a041388  0.301
2020 Balmain A. The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk. Nature Genetics. 52: 1139-1143. PMID 33106632 DOI: 10.1038/s41588-020-00727-5  0.317
2020 Ku AA, Hu HM, Zhao X, Shah KN, Kongara S, Wu D, McCormick F, Balmain A, Bandyopadhyay S. Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility. Nature Communications. 11: 2375. PMID 32398776 DOI: 10.1038/S41467-020-16078-Y  0.352
2020 Rose Li Y, Halliwill KD, Adams CJ, Iyer V, Riva L, Mamunur R, Jen KY, Del Rosario R, Fredlund E, Hirst G, Alexandrov LB, Adams D, Balmain A. Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice. Nature Communications. 11: 394. PMID 31959748 DOI: 10.1038/S41467-019-14261-4  0.33
2020 Mahaffety JP, Amendola CR, Chen W, Kimmelman A, Balmain A, Philips MR. Abstract A13: KRAS4A directly regulates hexokinase 1 Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Ras18-A13  0.353
2019 Amendola CR, Mahaffey JP, Parker SJ, Ahearn IM, Chen WC, Zhou M, Court H, Shi J, Mendoza SL, Morten MJ, Rothenberg E, Gottlieb E, Wadghiri YZ, Possemato R, Hubbard SR, ... Balmain A, et al. KRAS4A directly regulates hexokinase 1. Nature. PMID 31827279 DOI: 10.1038/S41586-019-1832-9  0.352
2019 Dodagatta-Marri E, Meyer DS, Reeves MQ, Paniagua R, To MD, Binnewies M, Broz ML, Mori H, Wu D, Adoumie M, Del Rosario R, Li O, Buchmann T, Liang B, Malato J, ... ... Balmain A, et al. α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas. Journal For Immunotherapy of Cancer. 7: 62. PMID 30832732 DOI: 10.1186/S40425-018-0493-9  0.344
2019 Li YR, Halliwill K, Adams C, Iyer V, Riva L, Rosario Rd, Fredlund E, Adams D, Balmain A. Genomic Mutational Signatures in Tumors Induced By High and Low Energy Radiation in Trp53-deficient Mouse Models International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1048  0.342
2019 Tee P, Balmain A. Critical behavior of spatial networks as a model of paracrine signaling in tumorigenesis Applied Network Science. 4: 47. DOI: 10.1007/S41109-019-0167-7  0.344
2018 Li S, Balmain A, Counter CM. A model for RAS mutation patterns in cancers: finding the sweet spot. Nature Reviews. Cancer. PMID 30420765 DOI: 10.1038/S41568-018-0076-6  0.375
2018 Reeves MQ, Kandyba E, Harris S, Del Rosario R, Balmain A. Multicolour lineage tracing reveals clonal dynamics of squamous carcinoma evolution from initiation to metastasis. Nature Cell Biology. 20: 699-709. PMID 29802408 DOI: 10.1038/S41556-018-0109-0  0.329
2018 Balmain A. Abstract IA15: Normal and cancer stem cells in multistage carcinogenesis Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-Ia15  0.49
2017 Quigley DA, Tahiri A, Lüders T, Riis MH, Balmain A, Børresen-Dale AL, Bukholm I, Kristensen V. Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue. Oncoimmunology. 6: e1356142. PMID 29147603 DOI: 10.1080/2162402X.2017.1356142  0.345
2017 Huang PY, Kandyba E, Jabouille A, Sjolund J, Kumar A, Halliwill K, McCreery M, DelRosario R, Kang HC, Wong CE, Seibler J, Beuger V, Pellegrino M, Sciambi A, Eastburn DJ, ... Balmain A, et al. Lgr6 is a stem cell marker in mouse skin squamous cell carcinoma. Nature Genetics. PMID 28945253 DOI: 10.1038/Ng.3957  0.388
2016 Halliwill KD, Quigley DA, Kang HC, Del Rosario R, Ginzinger D, Balmain A. Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer. Genome Medicine. 8: 83. PMID 27506198 DOI: 10.1186/S13073-016-0334-8  0.306
2016 Quigley DA, Kandyba E, Huang P, Halliwill KD, Sjölund J, Pelorosso F, Wong CE, Hirst GL, Wu D, Delrosario R, Kumar A, Balmain A. Gene Expression Architecture of Mouse Dorsal and Tail Skin Reveals Functional Differences in Inflammation and Cancer. Cell Reports. PMID 27425619 DOI: 10.1016/J.Celrep.2016.06.061  0.405
2016 Quigley DA, Tahiri A, Lüders T, Riis MH, Balmain A, Børresen-Dale A, Bukholm IR, Kristensen V. Abstract B59: Age and estrogen-dependent inflammation in breast adenocarcinoma and normal breast tissue Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B59  0.338
2016 McCreery MQ, Balmain A. Abstract 2376: Clonal evolution of skin carcinomas during tumor progression and metastasis Cancer Research. 76: 2376-2376. DOI: 10.1158/1538-7445.Am2016-2376  0.405
2015 Wang MT, Holderfield M, Galeas J, Delrosario R, To MD, Balmain A, McCormick F. K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling. Cell. 163: 1237-51. PMID 26590425 DOI: 10.1016/J.Cell.2015.10.041  0.332
2015 McCreery MQ, Halliwill KD, Chin D, Delrosario R, Hirst G, Vuong P, Jen KY, Hewinson J, Adams DJ, Balmain A. Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers. Nature Medicine. PMID 26523969 DOI: 10.1038/Nm.3979  0.444
2015 Adams CJ, Yu JS, Mao JH, Jen KY, Costes SV, Wade M, Shoemake J, Aina OH, Del Rosario R, Menchavez PT, Cardiff RD, Wahl GM, Balmain A. The Trp53 delta proline (Trp53ΔP) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor development. Molecular Carcinogenesis. PMID 26310697 DOI: 10.1002/Mc.22377  0.408
2015 Hiraoka K, Inoue T, Taylor RD, Watanabe T, Koshikawa N, Yoda H, Shinohara K, Takatori A, Sugimoto H, Maru Y, Denda T, Fujiwara K, Balmain A, Ozaki T, Bando T, et al. Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole-imidazole polyamide conjugate. Nature Communications. 6: 6706. PMID 25913614 DOI: 10.1038/Ncomms7706  0.36
2015 Letteboer TG, Benzinou M, Merrick CB, Quigley DA, Zhau K, Kim IJ, To MD, Jablons DM, van Amstel JK, Westermann CJ, Giraud S, Dupuis-Girod S, Lesca G, Berg JH, Balmain A, et al. Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14. Frontiers in Genetics. 6: 67. PMID 25815003 DOI: 10.3389/Fgene.2015.00067  0.34
2015 Chen J, Hackett CS, Zhang S, Song YK, Bell RJ, Molinaro AM, Quigley DA, Balmain A, Song JS, Costello JF, Gustafson WC, Van Dyke T, Kwok PY, Khan J, Weiss WA. The genetics of splicing in neuroblastoma. Cancer Discovery. 5: 380-95. PMID 25637275 DOI: 10.1158/2159-8290.Cd-14-0892  0.39
2015 Westcott PM, Halliwill KD, To MD, Rashid M, Rust AG, Keane TM, Delrosario R, Jen KY, Gurley KE, Kemp CJ, Fredlund E, Quigley DA, Adams DJ, Balmain A. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature. 517: 489-92. PMID 25363767 DOI: 10.1038/Nature13898  0.383
2015 Quigley D, Silwal-Pandit L, Dannenfelser R, Langerød A, Vollan HK, Vaske C, Siegel JU, Troyanskaya O, Chin SF, Caldas C, Balmain A, Børresen-Dale AL, Kristensen V. Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53. Molecular Cancer Research : McR. 13: 493-501. PMID 25351767 DOI: 10.1158/1541-7786.Mcr-14-0387  0.349
2015 Song IY, Balmain A. Cellular reprogramming in skin cancer. Seminars in Cancer Biology. 32: 32-39. PMID 24721247 DOI: 10.1016/J.Semcancer.2014.03.006  0.381
2015 Westcott PM, To MD, Delrosario R, Halliwill KD, Balmain A. Abstract A1-20: Genetic control of Kras mutation specificity in mice Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A1-20  0.414
2015 Quigley DA, Vaske C, Silwa-Pandit L, Dannenfelser R, Langerød A, Vollan HKM, Troyanskaya O, Chin S, Caldas C, Balmain A, Børresen-Dale A, Kristensen V. Abstract PR06: Lymphocyte invasion of basal breast tumors is associated with wild-type p53 Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Pr06  0.385
2015 Westcott PM, To MD, Delrosario R, Halliwill KD, Vuong P, McCreery MQ, Balmain A. Abstract LB-134: A novel model to investigate Kras mutation specificity in the skin Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-134  0.307
2014 Hackett CS, Quigley DA, Wong RA, Chen J, Cheng C, Song YK, Wei JS, Pawlikowska L, Bao Y, Goldenberg DD, Nguyen K, Gustafson WC, Rallapalli SK, Cho YJ, Cook JM, ... ... Balmain A, et al. Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma. Cell Reports. 9: 1034-46. PMID 25437558 DOI: 10.1016/J.Celrep.2014.09.046  0.314
2014 Balmain A, Yuspa SH. Milestones in skin carcinogenesis: the biology of multistage carcinogenesis. The Journal of Investigative Dermatology. 134: E2-7. PMID 25302469 DOI: 10.1038/Skinbio.2014.2  0.387
2014 Huang PY, Balmain A. Modeling cutaneous squamous carcinoma development in the mouse. Cold Spring Harbor Perspectives in Medicine. 4: a013623. PMID 25183851 DOI: 10.1101/Cshperspect.A013623  0.45
2014 Sjölund J, Pelorosso FG, Quigley DA, DelRosario R, Balmain A. Identification of Hipk2 as an essential regulator of white fat development. Proceedings of the National Academy of Sciences of the United States of America. 111: 7373-8. PMID 24785298 DOI: 10.1073/Pnas.1322275111  0.362
2014 Quigley DA, Fiorito E, Nord S, Van Loo P, Alnæs GG, Fleischer T, Tost J, Moen Vollan HK, Tramm T, Overgaard J, Bukholm IR, Hurtado A, Balmain A, Børresen-Dale AL, Kristensen V. The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors. Molecular Oncology. 8: 273-84. PMID 24388359 DOI: 10.1016/J.Molonc.2013.11.008  0.383
2014 Chen J, Hackett CS, Zhang S, Song YK, Molinaro A, Quigley DA, Balmain A, Gustafson WC, Dyke TAV, Kwok P, Khan J, Weiss WA. Abstract 3413: A genetic analysis of splicing in neuroblastoma identifies opposing functions for FUBP1 splice variants in MYC regulation Cancer Research. 74: 3413-3413. DOI: 10.1158/1538-7445.Am2014-3413  0.387
2014 Barcellos-Hoff MH, Adams C, Balmain A, Costes SV, Demaria S, Illa-Bochaca I, Mao JH, Ouyang H, Sebastiano C, Tang J. Systems biology perspectives on the carcinogenic potential of radiation Journal of Radiation Research. 55. DOI: 10.1093/Jrr/Rrt211  0.341
2013 Lessard JC, Piña-Paz S, Rotty JD, Hickerson RP, Kaspar RL, Balmain A, Coulombe PA. Keratin 16 regulates innate immunity in response to epidermal barrier breach Proceedings of the National Academy of Sciences of the United States of America. 110: 19537-19542. PMID 24218583 DOI: 10.1073/Pnas.1309576110  0.345
2013 Saunders SP, Goh CS, Brown SJ, Palmer CN, Porter RM, Cole C, Campbell LE, Gierlinski M, Barton GJ, Schneider G, Balmain A, Prescott AR, Weidinger S, Baurecht H, Kabesch M, et al. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. The Journal of Allergy and Clinical Immunology. 132: 1121-9. PMID 24084074 DOI: 10.1016/J.Jaci.2013.08.046  0.339
2013 Kim IJ, Quigley D, To MD, Pham P, Lin K, Jo B, Jen KY, Raz D, Kim J, Mao JH, Jablons D, Balmain A. Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas. Nature Communications. 4: 1701. PMID 23591868 DOI: 10.1038/Ncomms2660  0.316
2013 Wong CE, Yu JS, Quigley DA, To MD, Jen KY, Huang PY, Del Rosario R, Balmain A. Inflammation and Hras signaling control epithelial-mesenchymal transition during skin tumor progression. Genes & Development. 27: 670-82. PMID 23512660 DOI: 10.1101/Gad.210427.112  0.419
2013 Kang HC, Quigley DA, Kim IJ, Wakabayashi Y, Ferguson-Smith MA, D'Alessandro M, Birgitte Lane E, Akhurst RJ, Goudie DR, Balmain A. Multiple self-healing squamous epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to known TGFBR1 mutations suggest a digenic or multilocus etiology. The Journal of Investigative Dermatology. 133: 1907-10. PMID 23358096 DOI: 10.1038/Jid.2013.45  0.347
2013 Nguyen DH, Fredlund E, Zhao W, Perou CM, Balmain A, Mao JH, Barcellos-Hoff MH. Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1353-62. PMID 23339125 DOI: 10.1158/1078-0432.Ccr-12-3554  0.373
2013 Kang HC, Wakabayashi Y, Jen KY, Mao JH, Zoumpourlis V, Del Rosario R, Balmain A. Ptch1 overexpression drives skin carcinogenesis and developmental defects in K14Ptch(FVB) mice. The Journal of Investigative Dermatology. 133: 1311-20. PMID 23223138 DOI: 10.1038/Jid.2012.419  0.411
2013 To MD, Rosario RD, Westcott PM, Banta KL, Balmain A. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. Oncogene. 32: 4028-33. PMID 22945650 DOI: 10.1038/Onc.2012.404  0.409
2013 Song IY, Kumar A, Delrosario R, Mao J, Balmain A. Abstract LB-258: The human Aurora-A kinase Phe31Ile polymorphism affects cancer susceptibility in a knock-in mouse model. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-258  0.367
2012 Kwon YW, Kim IJ, Wu D, Lu J, Stock WA, Liu Y, Huang Y, Kang HC, DelRosario R, Jen KY, Perez-Losada J, Wei G, Balmain A, Mao JH. Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development. Molecular Cancer Research : McR. 10: 834-44. PMID 22513362 DOI: 10.1158/1541-7786.Mcr-12-0025  0.385
2012 Perez-Losada J, Wu D, DelRosario R, Balmain A, Mao JH. Allele-specific deletions in mouse tumors identify Fbxw7 as germline modifier of tumor susceptibility. Plos One. 7: e31301. PMID 22348067 DOI: 10.1371/Journal.Pone.0031301  0.441
2012 Jen KY, Song IY, Banta KL, Wu D, Mao JH, Balmain A. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas. Blood. 119: 805-9. PMID 22117044 DOI: 10.1182/Blood-2011-01-327619  0.352
2012 Nguyen DH, Fredlund E, Zhao W, Perou CM, Balmain A, Mao J, Barcellos-Hoff MH. Abstract 4268: Gene signature of host irradiation from Trp53 null mammary tumors detects radiation-preceded human cancers and has prognostic value for sporadic human breast cancer Cancer Research. 72: 4268-4268. DOI: 10.1158/1538-7445.Am2012-4268  0.403
2012 Quigley D, Loo PV, Alnæs G, Tost J, Zelenika D, Balmain A, Børresen-Dale A, Kristensen V. Abstract P5-05-03: The 5p12 breast cancer susceptibility locus is associated with MRPS30 expression in estrogen receptor - positive tumors Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P5-05-03  0.367
2011 To MD, Quigley DA, Mao JH, Del Rosario R, Hsu J, Hodgson G, Jacks T, Balmain A. Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer. Molecular Cancer Research : McR. 9: 1339-45. PMID 21807965 DOI: 10.1158/1541-7786.Mcr-11-0219  0.392
2011 Wang YV, Leblanc M, Fox N, Mao JH, Tinkum KL, Krummel K, Engle D, Piwnica-Worms D, Piwnica-Worms H, Balmain A, Kaushansky K, Wahl GM. Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes & Development. 25: 1426-38. PMID 21724834 DOI: 10.1101/Gad.2024411  0.342
2011 Quigley DA, To MD, Kim IJ, Lin KK, Albertson DG, Sjolund J, Pérez-Losada J, Balmain A. Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility. Genome Biology. 12: R5. PMID 21244661 DOI: 10.1186/Gb-2011-12-1-R5  0.435
2010 Pelorosso FG, Balmain A. C/EBPδ: friend or foe? a novel role for C/EBPδ in metastasis. The Embo Journal. 29: 4063-5. PMID 21157479 DOI: 10.1038/Emboj.2010.308  0.338
2010 Chun MG, Mao JH, Chiu CW, Balmain A, Hanahan D. Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 107: 17268-73. PMID 20855625 DOI: 10.1073/Pnas.1012705107  0.406
2010 Climent J, Perez-Losada J, Quigley DA, Kim IJ, Delrosario R, Jen KY, Bosch A, Lluch A, Mao JH, Balmain A. Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3770-8. PMID 20625127 DOI: 10.1200/Jco.2009.27.0215  0.33
2010 Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, et al. Guidelines for the welfare and use of animals in cancer research British Journal of Cancer. 102: 1555-1577. PMID 20502460 DOI: 10.1038/Sj.Bjc.6605642  0.31
2010 Li Z, Zhang Q, Mao JH, Weise A, Mrasek K, Fan X, Zhang X, Liehr T, Lu KH, Balmain A, Cai WW. An HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis Oncogene. 29: 2659-2671. PMID 20154723 DOI: 10.1038/Onc.2010.19  0.34
2010 Li Z, Zhang Q, Mao J, Weise A, Mrasek K, Fan X, Zhang X, Liehr T, Lu KH, Balmain A, Cai W. Abstract 254: A HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis Cancer Research. 70: 254-254. DOI: 10.1158/1538-7445.Am10-254  0.36
2010 To M, Quigley D, Sjolund J, Balmain A. 606 Evolution of genetic and gene expression networks during tumour development Ejc Supplements. 8: 155. DOI: 10.1016/S1359-6349(10)71407-5  0.305
2010 Yu J, Mao J, Wade M, Del Rosario R, Wu D, Cardiff R, Wahl G, Balmain A. Mice Lacking the Proline-rich Domain of p53 Are Exquisitely Sensitive to Epithelial Tumor Development after Gamma-Irradiation International Journal of Radiation Oncology*Biology*Physics. 78: S88-S89. DOI: 10.1016/J.Ijrobp.2010.07.236  0.328
2009 Quigley D, Balmain A. Systems genetics analysis of cancer susceptibility: from mouse models to humans. Nature Reviews. Genetics. 10: 651-7. PMID 19636343 DOI: 10.1038/Nrg2617  0.352
2009 Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, Hann B, Solari A, Bobisse S, Rondina MB, Guzzardo V, Parenti AR, Rosato A, Bicciato S, Balmain A, Piccolo S. A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell. 137: 87-98. PMID 19345189 DOI: 10.1016/J.Cell.2009.01.039  0.366
2009 Quigley DA, To MD, Pérez-Losada J, Pelorosso FG, Mao JH, Nagase H, Ginzinger DG, Balmain A. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature. 458: 505-8. PMID 19136944 DOI: 10.1038/Nature07683  0.4
2008 Mahler KL, Fleming JL, Dworkin AM, Gladman N, Cho HY, Mao JH, Balmain A, Toland AE. Sequence divergence of Mus spretus and Mus musculus across a skin cancer susceptibility locus Bmc Genomics. 9. PMID 19105829 DOI: 10.1186/1471-2164-9-626  0.307
2008 Mao JH, Kim IJ, Wu D, Climent J, Kang HC, DelRosario R, Balmain A. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science (New York, N.Y.). 321: 1499-502. PMID 18787170 DOI: 10.1126/Science.1162981  0.398
2008 To MD, Wong CE, Karnezis AN, Del Rosario R, Di Lauro R, Balmain A. Kras regulatory elements and exon 4A determine mutation specificity in lung cancer. Nature Genetics. 40: 1240-4. PMID 18758463 DOI: 10.1038/Ng.211  0.408
2008 Mao JH, Wu D, DelRosario R, Castellanos A, Balmain A, Perez-Losada J. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background Oncogene. 27: 6596-6600. PMID 18679420 DOI: 10.1038/Onc.2008.280  0.429
2008 Chiaverotti T, Couto SS, Donjacour A, Mao JH, Nagase H, Cardiff RD, Cunha GR, Balmain A. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. The American Journal of Pathology. 172: 236-46. PMID 18156212 DOI: 10.2353/Ajpath.2008.070602  0.319
2007 Wei G, Ku S, Ma GK, Saito S, Tang AA, Zhang J, Mao JH, Appella E, Balmain A, Huang EJ. HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 104: 13040-5. PMID 17666529 DOI: 10.1073/Pnas.0703213104  0.375
2007 De Koning JP, Wakabayashi Y, Nagase H, Mao JH, Balmain A. Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus Oncogene. 26: 4171-4178. PMID 17311004 DOI: 10.1038/Sj.Onc.1210206  0.439
2007 Mao JH, Wu D, Perez-Losada J, Jiang T, Li Q, Neve RM, Gray JW, Cai WW, Balmain A. Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice. Cancer Cell. 11: 161-73. PMID 17292827 DOI: 10.1016/J.Ccr.2006.11.025  0.41
2007 Wakabayashi Y, Mao JH, Brown K, Girardi M, Balmain A. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature. 445: 761-5. PMID 17230190 DOI: 10.1038/Nature05489  0.412
2006 To MD, Perez-Losada J, Mao JH, Hsu J, Jacks T, Balmain A. A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nature Genetics. 38: 926-30. PMID 16823377 DOI: 10.1038/Ng1836  0.39
2006 Mao JH, Saunier EF, de Koning JP, McKinnon MM, Higgins MN, Nicklas K, Yang HT, Balmain A, Akhurst RJ. Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. Proceedings of the National Academy of Sciences of the United States of America. 103: 8125-30. PMID 16702541 DOI: 10.1073/Pnas.0602581103  0.404
2006 Lacher MD, Tiirikainen MI, Saunier EF, Christian C, Anders M, Oft M, Balmain A, Akhurst RJ, Korn WM. Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition. Cancer Research. 66: 1648-57. PMID 16452224 DOI: 10.1158/0008-5472.Can-05-2328  0.33
2006 Balmain A, Montell D. Oncogenes and cell proliferation: Shifting paradigms in the understanding and treatment of cancer Current Opinion in Genetics and Development. 16: 1-3. DOI: 10.1016/J.Gde.2005.12.013  0.335
2005 To MD, Perez-Losada J, Mao JH, Balmain A. Crosstalk between Pten and Ras signaling pathways in tumor development. Cell Cycle (Georgetown, Tex.). 4: 1185-8. PMID 16123588 DOI: 10.4161/Cc.4.9.2039  0.422
2005 Mao JH, Li J, Jiang T, Li Q, Wu D, Perez-Losada J, DelRosario R, Peterson L, Balmain A, Cai WW. Genomic instability in radiation-induced mouse lymphoma from p53 heterozygous mice. Oncogene. 24: 7924-34. PMID 16116484 DOI: 10.1038/Sj.Onc.1208926  0.364
2005 Perez-Losada J, Mao JH, Balmain A. Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathway. Cancer Research. 65: 6488-92. PMID 16061623 DOI: 10.1158/0008-5472.Can-05-1294  0.431
2005 Perez-Losada J, Wu D, DelRosario R, Balmain A, Mao JH. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo. Oncogene. 24: 5521-4. PMID 16007185 DOI: 10.1038/Sj.Onc.1208799  0.349
2005 Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, ... ... Balmain A, et al. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis. 26: 1368-73. PMID 15802297 DOI: 10.1093/Carcin/Bgi085  0.342
2004 Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, Brown K, Bryson S, Balmain A. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature. 432: 775-9. PMID 15592418 DOI: 10.1038/Nature03155  0.413
2004 Hsu SJ, Nagase H, Balmain A. Identification of Fetuin-B as a member of a cystatin-like gene family on mouse chromosome 16 with tumor suppressor activity. Genome / National Research Council Canada = GéNome / Conseil National De Recherches Canada. 47: 931-46. PMID 15499407 DOI: 10.1139/G04-043  0.413
2004 Hirst GL, Balmain A. Forty years of cancer modelling in the mouse European Journal of Cancer. 40: 1974-1980. PMID 15315806 DOI: 10.1016/J.Ejca.2004.05.013  0.368
2004 Fraga MF, Herranz M, Espada J, Ballestar E, Paz MF, Ropero S, Erkek E, Bozdogan O, Peinado H, Niveleau A, Mao JH, Balmain A, Cano A, Esteller M. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Research. 64: 5527-34. PMID 15313885 DOI: 10.1158/0008-5472.Can-03-4061  0.308
2004 Mao JH, To MD, Perez-Losada J, Wu D, Del Rosario R, Balmain A. Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes & Development. 18: 1800-5. PMID 15289454 DOI: 10.1101/Gad.1213804  0.425
2004 Ewart-Toland A, Balmain A. The genetics of cancer susceptibility: from mouse to man. Toxicologic Pathology. 32: 26-30. PMID 15209400 DOI: 10.1080/01926230490424716  0.419
2004 Girardi M, Oppenheim D, Glusac EJ, Filler R, Balmain A, Tigelaar RE, Hayday AC. Characterizing the protective component of the alphabeta T cell response to transplantable squamous cell carcinoma. The Journal of Investigative Dermatology. 122: 699-706. PMID 15086556 DOI: 10.1111/J.0022-202X.2004.22342.X  0.357
2003 Mao JH, Wu D, Perez-Losada J, Nagase H, DelRosario R, Balmain A. Genetic interactions between Pten and p53 in radiation-induced lymphoma development. Oncogene. 22: 8379-85. PMID 14627978 DOI: 10.1038/Sj.Onc.1207083  0.415
2003 Hann B, Balmain A. Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants. Journal of Virology. 77: 11588-95. PMID 14557644 DOI: 10.1128/Jvi.77.21.11588-11595.2003  0.374
2003 Nagase H, Mao JH, Balmain A. Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Research. 63: 4849-53. PMID 12941805  0.318
2003 de Koning JP, Mao JH, Balmain A. Novel approaches to identify low-penetrance cancer susceptibility genes using mouse models. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 163: 19-27; discussion 26. PMID 12903840 DOI: 10.1007/978-3-642-55647-0_3  0.414
2003 Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, Ball S, Almeida M, Linardopoulos S, Balmain A. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nature Genetics. 34: 403-12. PMID 12881723 DOI: 10.1038/Ng1220  0.442
2003 Perez-Losada J, Balmain A. Stem-cell hierarchy in skin cancer. Nature Reviews. Cancer. 3: 434-43. PMID 12778133 DOI: 10.1038/Nrc1095  0.346
2003 Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nature Genetics. 33: 238-44. PMID 12610533 DOI: 10.1038/Ng1107  0.425
2003 Mao JH, Balmain A. Genomic approaches to identification of tumour-susceptibility genes using mouse models. Current Opinion in Genetics & Development. 13: 14-9. PMID 12573430 DOI: 10.1016/S0959-437X(03)00005-4  0.386
2003 Yan W, Kitzes G, Dormishian F, Hawkins L, Sampson-Johannes A, Watanabe J, Holt J, Lee V, Dubensky T, Fattaey A, Hermiston T, Balmain A, Shen Y. Developing novel oncolytic adenoviruses through bioselection. Journal of Virology. 77: 2640-50. PMID 12552003 DOI: 10.1128/Jvi.77.4.2640-2650.2003  0.347
2003 Hodgson G, Hager J, Chin K, Lapuk C, Volik S, Collins C, Balmain A, Waldman F, Hanahan D, Gray J. The comparative genetics and genomics of cancer: of mice and men. Breast Cancer Research. 5: 24-24. DOI: 10.1186/Bcr683  0.41
2002 Oft M, Akhurst RJ, Balmain A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nature Cell Biology. 4: 487-94. PMID 12105419 DOI: 10.1038/Ncb807  0.341
2002 Psichari E, Balmain A, Plows D, Zoumpourlis V, Pintzas A. High activity of serum response factor in the mesenchymal transition of epithelial tumor cells is regulated by RhoA signaling. The Journal of Biological Chemistry. 277: 29490-5. PMID 12039949 DOI: 10.1074/Jbc.M112368200  0.345
2002 Balmain A. Cancer: new-age tumour suppressors. Nature. 417: 235-7. PMID 12015584 DOI: 10.1038/417235A  0.379
2002 Cai WW, Mao JH, Chow CW, Damani S, Balmain A, Bradley A. Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nature Biotechnology. 20: 393-6. PMID 11923847 DOI: 10.1038/Nbt0402-393  0.326
2002 Balmain A. Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell. 108: 145-52. PMID 11832205 DOI: 10.1016/S0092-8674(02)00622-0  0.379
2002 Bergo MO, Ambroziak P, Gregory C, George A, Otto JC, Kim E, Nagase H, Casey PJ, Balmain A, Young SG. Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation. Molecular and Cellular Biology. 22: 171-81. PMID 11739732 DOI: 10.1128/Mcb.22.1.171-181.2002  0.359
2002 Koning JPd, Ewart-Toland A, Mao J, Nagase H, Balmain A. Session 2 S3. Approaches to identify low penetrance cancer susceptibility genes using mouse models European Journal of Cancer. 38. DOI: 10.1016/S0959-8049(02)80611-6  0.353
2001 Hann B, Balmain A. Building 'validated' mouse models of human cancer Current Opinion in Cell Biology. 13: 778-784. PMID 11698196 DOI: 10.1016/S0955-0674(00)00283-0  0.366
2001 Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics. 29: 117-29. PMID 11586292 DOI: 10.1038/Ng1001-117  0.352
2001 Balmain A. Cancer genetics: From Boveri and Mendel to microarrays Nature Reviews Cancer. 1: 77-82. DOI: 10.1038/35094086  0.328
2000 Linardopoulos S, Silva S, Klein G, Balmain A. Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying Eμ-c-myc or N-myc transgenes International Journal of Cancer. 88: 920-927. PMID 11093815 DOI: 10.1002/1097-0215(20001215)88:6<920::Aid-Ijc13>3.0.Co;2-#  0.352
2000 Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model Oncogene. 19: 4011-4021. PMID 10962557 DOI: 10.1038/Sj.Onc.1203732  0.347
2000 Balmain A, Harris CC. Carcinogenesis in mouse and human cells: Parallels and paradoxes Carcinogenesis. 21: 371-377. PMID 10688857 DOI: 10.1093/Carcin/21.3.371  0.403
2000 Ganly I, Mautner V, Balmain A. Productive replication of human adenoviruses in mouse epidermal cells Journal of Virology. 74: 2895-2899. PMID 10684307 DOI: 10.1128/Jvi.74.6.2895-2899.2000  0.341
2000 Frame S, Balmain A. Integration of positive and negative growth signals during ras pathway activation in vivo Current Opinion in Genetics and Development. 10: 106-113. PMID 10679397 DOI: 10.1016/S0959-437X(99)00052-0  0.311
2000 Zhu J, Gao B, Zhao J, Balmain A. Targeting gene expression to tumor cells with loss of wild-type p53 function Cancer Gene Therapy. 7: 4-12. PMID 10678350 DOI: 10.1038/Sj.Cgt.7700091  0.388
1999 Nagase H, Mao JH, Balmain A. A subset of skin tumor modifier loci determines survival time of tumor- bearing mice Proceedings of the National Academy of Sciences of the United States of America. 96: 15032-15037. PMID 10611333 DOI: 10.1073/Pnas.96.26.15032  0.429
1999 Akhurst RJ, Balmain A. Genetic events and the role of TGFβ in epithelial tumour progression Journal of Pathology. 187: 82-90. PMID 10341708 DOI: 10.1002/(Sici)1096-9896(199901)187:1<82::Aid-Path248>3.0.Co;2-8  0.455
1999 Dyson N, Balmain A. Oncogenes and cell proliferation: Editorial overview Current Opinion in Genetics and Development. 9: 11-14. PMID 10206674 DOI: 10.1016/S0959-437X(99)80002-1  0.305
1998 Frame S, Crombie R, Liddell J, Stuart D, Linardopoulos S, Nagase H, Portella G, Brown K, Street A, Akhurst R, Balmain A. Epithelial carcinogenesis in the mouse: Correlating the genetics and the biology Philosophical Transactions of the Royal Society B: Biological Sciences. 353: 839-845. PMID 9684281 DOI: 10.1098/Rstb.1998.0248  0.439
1998 Balmain A, Nagase H. Cancer resistance genes in mice: Models for the study of tumour modifiers Trends in Genetics. 14: 139-144. PMID 9594661 DOI: 10.1016/S0168-9525(98)01422-X  0.346
1998 Brown K, Strathdee D, Bryson S, Lambie W, Balmain A. The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Current Biology : Cb. 8: 516-24. PMID 9560338 DOI: 10.1016/S0960-9822(98)70203-9  0.411
1998 Mao JH, Lindsay KA, Balmain A, Wheldon TE. Stochastic modelling of tumorigenesis in p53 deficient mice British Journal of Cancer. 77: 243-252. PMID 9460995 DOI: 10.1038/Bjc.1998.40  0.326
1997 Gause PR, Lluria-Prevatt M, Keith WN, Balmain A, Linardopolous S, Warneke J, Powell MB. Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene- induced melanoma from TP-ras transgenic mice Molecular Carcinogenesis. 20: 78-87. PMID 9328438 DOI: 10.1002/(Sici)1098-2744(199709)20:1<78::Aid-Mc9>3.0.Co;2-E  0.418
1997 Holden PR, McGuire B, Stoler A, Balmain A, Pitts JD. Changes in gap junctional intercellular communication in mouse skin carcinogenesis. Carcinogenesis. 18: 15-21. PMID 9054584 DOI: 10.1093/Carcin/18.1.15  0.344
1996 Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 86: 531-42. PMID 8752208 DOI: 10.1016/S0092-8674(00)80127-0  0.417
1996 Cano A, Gamallo C, Kemp CJ, Benito N, Palacios J, Quintanilla M, Balmain A. Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha 6 beta 4 intergrin is altered in pre-malignant skin tumors of p53-deficient mice. International Journal of Cancer. Journal International Du Cancer. 65: 254-62. PMID 8567126 DOI: 10.1002/(Sici)1097-0215(19960117)65:2<254::Aid-Ijc21>3.0.Co;2-C  0.351
1995 Brown K, Burns PA, Balmain A. Transgenic approaches to understanding the mechanisms of chemical carcinogenesis in mouse skin Toxicology Letters. 82: 123-130. PMID 8597039 DOI: 10.1016/0378-4274(95)03549-4  0.388
1995 Telliez JB, Plumb M, Balmain A, Bailleul B. Regulatory elements in the first intron of the mouse Ha-ras gene Molecular Carcinogenesis. 12: 137-145. PMID 7893367 DOI: 10.1002/Mc.2940120305  0.35
1995 Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, Balmain A. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nature Genetics. 10: 424-9. PMID 7670492 DOI: 10.1038/Ng0895-424  0.37
1995 Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ, Balmain A. Deletion and altered regulation p16INK4a and p15INK4b in undifferentiated mouse skin tumors Cancer Research. 55: 5168-5172. PMID 7585567  0.328
1995 Brown K, Balmain A. Transgenic mice and squamous multistage skin carcinogenesis Cancer and Metastasis Reviews. 14: 113-124. PMID 7554029 DOI: 10.1007/Bf00665795  0.377
1994 Brown K, Kemp C, Burns P, Balmain A. Importance of genetic alterations in tumour development. Archives of Toxicology. Supplement. = Archiv Fã¼R Toxikologie. Supplement. 16: 253-60. PMID 8192588 DOI: 10.1007/978-3-642-78640-2_28  0.355
1994 Wright JH, McDonnell S, Portella G, Bowden GT, Balmain A, Matrisian LM. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Molecular Carcinogenesis. 10: 207-15. PMID 8068181 DOI: 10.1002/Mc.2940100405  0.386
1994 Kemp CJ, Wheldon T, Balmain A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genetics. 8: 66-9. PMID 7987394 DOI: 10.1038/Ng0994-66  0.336
1994 Bremner R, Kemp CJ, Balmain A. Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors. Molecular Carcinogenesis. 11: 90-7. PMID 7916997 DOI: 10.1002/Mc.2940110206  0.43
1994 Portella G, Liddell J, Crombie R, Haddow S, Clarke M, Stoler AB, Balmain A. Molecular mechanisms of invasion and metastasis during mouse skin tumour progression Invasion and Metastasis. 14: 7-16. PMID 7657534  0.309
1994 Kemp CJ, Burns PA, Brown K, Nagase H, Balmain A. Transgenic approaches to the analysis of ras and p53 function in multistage carcinogenesis Cold Spring Harbor Symposia On Quantitative Biology. 59: 427-434. PMID 7587097 DOI: 10.1101/Sqb.1994.059.01.048  0.302
1993 Fowlis DJ, Balmain A. Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia European Journal of Cancer. 29: 638-645. PMID 8435223 DOI: 10.1016/S0959-8049(05)80170-4  0.361
1993 Kemp CJ, Donehower LA, Bradley A, Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors Cell. 74: 813-822. PMID 8374952 DOI: 10.1016/0092-8674(93)90461-X  0.431
1993 Brown K, Kemp CJ, Burns PA, Stoler AB, Fowlis DJ, Akhurst RJ, Balmain A. Positive and negative growth control in multistage skin carcinogenesis Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 128: 309-321. PMID 8356328 DOI: 10.1007/978-3-642-84881-0_23  0.377
1993 Kemp CJ, Bremner R, Balmain A. A revised map position for the Ha-ras gene on mouse chromosome 7: Implications for analysis of genetic alterations in rodent tumors Molecular Carcinogenesis. 7: 147-150. PMID 8098216 DOI: 10.1002/Mc.2940070304  0.395
1993 Stoler AB, Stenback F, Balmain A. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event Journal of Cell Biology. 122: 1103-1117. PMID 7689080 DOI: 10.1083/Jcb.122.5.1103  0.393
1991 Plumb M, Telliez JB, Fee F, Daubersies P, Bailleul B, Balmain A. Structural analysis of the mouse c-Ha-ras gene promoter Molecular Carcinogenesis. 4: 103-110. PMID 2043251 DOI: 10.1002/Mc.2940040205  0.339
1991 Quintanilla M, Haddow S, Jones D, Jaffe D, Bowden GT, Balmain A. Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo Carcinogenesis. 12: 1875-1881. PMID 1934268 DOI: 10.1093/Carcin/12.10.1875  0.391
1991 Buchmann A, Ruggeri B, Klein-Szanto AJP, Balmain A. Progression of Squamous Carcinoma Cells to Spindle Carcinomas of Mouse Skin Is Associated with an Imbalance of H-ras Alleles on Chromosome 7 Cancer Research. 51: 4097-4101. PMID 1855225  0.327
1991 Balmain A, Kemp CJ, Burns PA, Stoler AB, Fowlis DJ, Akhurst RJ. Functional loss of tumour suppressor genes in multistage chemical carcinogenesis Princess Takamatsu Symposia. 22: 97-108. PMID 1844254  0.328
1991 Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R, Balmain A. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice Oncogene. 6: 2363-2369. PMID 1766680  0.35
1991 Burns PA, Bremner R, Balmain A. Genetic changes during mouse skin tumorigenesis Environmental Health Perspectives. 93: 41-44. PMID 1685445 DOI: 10.1289/Ehp.919341  0.414
1990 Bremner R, Balmain A. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 Cell. 61: 407-417. PMID 2185890 DOI: 10.1016/0092-8674(90)90523-H  0.432
1990 Brown K, Buchmann A, Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression Proceedings of the National Academy of Sciences of the United States of America. 87: 538-542. PMID 2105486 DOI: 10.1073/Pnas.87.2.538  0.383
1990 Bailleul B, Surani MA, White S, Barton SC, Brown K, Blessing M, Jorcano J, Balmain A. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter Cell. 62: 697-708. PMID 1696852 DOI: 10.1016/0092-8674(90)90115-U  0.422
1989 Bailleul B, Brown K, Ramsden M, Akhurst RJ, Fee F, Balmain A. Chemical induction of oncogene mutations and growth factor activity in mouse skin carcinogenesis Environmental Health Perspectives. 81: 23-27. PMID 2667981 DOI: 10.1289/Ehp.898123  0.45
1988 Brown K, Bailleul B, Ramsden M, Fee F, Krumlauf R, Balmain A. Isolation and characterization of the 5' flanking region of the mouse c-Harvey-ras gene Molecular Carcinogenesis. 1: 161-170. PMID 3074812 DOI: 10.1002/Mc.2940010304  0.361
1988 Bailleul B, Lang J, Wilkie N, Balmain A. A human T24 ha-ras cassette suitable for expression studies in eukaryotic cells Nucleic Acids Research. 16: 359. PMID 2829123 DOI: 10.1093/Nar/16.1.359  0.308
1988 Balmain A, Brown K. Oncogene Activation in Chemical Carcinogenesis Advances in Cancer Research. 51: 147-182. DOI: 10.1016/S0065-230X(08)60222-5  0.399
1986 Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S, Balmain A. v-ras genes from harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis Cell. 46: 447-456. PMID 3015415 DOI: 10.1016/0092-8674(86)90665-3  0.395
1986 Quintanilla M, Brown K, Ramsden M, Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis Nature. 322: 78-80. PMID 3014349 DOI: 10.1038/322078A0  0.39
1986 Balmain A, Quintanilla M, Brown K, Ramsden M, Fee F, Young S. The role of ras gene mutations in initiation of chemical carcinogenesis Leukemia Research. 10: 737-738. DOI: 10.1016/0145-2126(86)90284-5  0.344
1985 Ramsden M, Cole G, Smith J, Balmain A. Differential methylation of the c-H-ras gene in normal mouse cells and during skin tumour progression Embo Journal. 4: 1449-1454. PMID 4029120 DOI: 10.1002/J.1460-2075.1985.Tb03801.X  0.352
1985 Kerr IB, Lee FD, Quintanilla M, Balmain A. Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum British Journal of Cancer. 52: 695-700. PMID 3904802 DOI: 10.1038/Bjc.1985.245  0.353
1984 Balmain A, Ramsden M, Bowden GT, Smith J. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas Nature. 307: 658-660. PMID 6694757 DOI: 10.1038/307658A0  0.401
1983 Balmain A, Pragnell IB. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene Nature. 303: 72-74. PMID 6843661 DOI: 10.1038/303072A0  0.387
1983 Koury MJ, Balmain A, Pragnell IB. Induction of granulocyte-macrophage colony-stimulating activity in mouse skin by inflammatory agents and tumor promoters Embo Journal. 2: 1877-1882. PMID 6605850 DOI: 10.1002/J.1460-2075.1983.Tb01674.X  0.329
Low-probability matches (unlikely to be authored by this person)
2010 Rocher-Ros V, Marco S, Mao JH, Gines S, Metzger D, Chambon P, Balmain A, Saura CA. Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7. Oncogene. 29: 2950-61. PMID 20208556 DOI: 10.1038/Onc.2010.57  0.3
1995 Balmain A. Cancer: Exploring the bowels of DNA methylation Current Biology. 5: 1013-1016. PMID 8542276 DOI: 10.1016/S0960-9822(95)00204-1  0.299
2010 Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, Gripp KW, Neri G, Carey JC, Legius E, Tartaglia M, Schubbert S, Roberts AE, Gelb BD, Shannon K, ... ... Balmain A, et al. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. American Journal of Medical Genetics. Part A. 152: 4-24. PMID 20014119 DOI: 10.1002/Ajmg.A.33183  0.297
1976 Balmain A. The synthesis of specific proteins in adult mouse epidermis during phases of proliferation and differentiation induced by the tumor promoter TPA, and in basal and differentiating layers of neonatal mouse epidermis Journal of Investigative Dermatology. 67: 246-253. PMID 950489 DOI: 10.1111/1523-1747.Ep12513451  0.295
1993 Kemp CJ, Fee F, Balmain A. Allelotype Analysis of Mouse Skin Ttimors Using Polymorphic Microsatellites: Sequential Genetic Alterations on Chromosomes Cancer Research. 53: 6022-6027. PMID 7903201  0.294
1986 Balmain A, Quintanilla M, Brown K, Ramsden M. An approach to the molecular mechanisms of cancer induction Journal of Pathology. 149: 3-8. PMID 3088239 DOI: 10.1002/Path.1711490103  0.291
1985 Balmain A. Transforming ras oncogenes and multistage carcinogenesis British Journal of Cancer. 51: 1-7. PMID 3881118 DOI: 10.1038/Bjc.1985.1  0.291
2014 Hiatt RA, Porco TC, Liu F, Balke K, Balmain A, Barlow J, Braithwaite D, Diez-Roux AV, Kushi LH, Moasser MM, Werb Z, Windham GC, Rehkopf DH. A multilevel model of postmenopausal breast cancer incidence. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2078-92. PMID 25017248 DOI: 10.1158/1055-9965.Epi-14-0403  0.29
1974 Balmain A, Hecker E. On the biochemical mechanism of tumorigenesis in mouse skin. VI. Early effects of growth-stimulating phorbol esters on phosphate transport and phospholipid synthesis in mouse epidermis. Biochimica Et Biophysica Acta. 362: 457-68. PMID 4414909 DOI: 10.1016/0304-4165(74)90141-X  0.287
2004 Li J, Jiang T, Mao JH, Balmain A, Peterson L, Harris C, Rao PH, Havlak P, Gibbs R, Cai WW. Genomic segmental polymorphisms in inbred mouse strains. Nature Genetics. 36: 952-4. PMID 15322544 DOI: 10.1038/Ng1417  0.286
2016 Gerhard DS, Clemons PA, Shamji AF, Hon C, Wagner BK, Schreiber SL, Krasnitz A, Sordella R, Sander C, Lowe SW, Powers S, Smith K, Aburi M, Iavarone A, Lasorella A, ... ... Balmain A, et al. Transforming Big Data into cancer-relevant insight: An initial, multi-tier approach to assess reproducibility and relevance. Molecular Cancer Research : McR. PMID 27401613 DOI: 10.1158/1541-7786.Mcr-16-0090  0.286
2019 Veniaminova NA, Grachtchouk M, Doane OJ, Peterson JK, Quigley DA, Lull MV, Pyrozhenko DV, Nair RR, Patrick MT, Balmain A, Dlugosz AA, Tsoi LC, Wong SY. Niche-Specific Factors Dynamically Regulate Sebaceous Gland Stem Cells in the Skin. Developmental Cell. PMID 31564613 DOI: 10.1016/J.Devcel.2019.08.015  0.286
2001 Ganly I, Kim YT, Hann B, Balmain A, Brown R. Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis Gene Therapy. 8: 369-375. PMID 11313813 DOI: 10.1038/Sj.Gt.3301402  0.284
2012 Mao JH, Wu D, Kim IJ, Kang HC, Wei G, Climent J, Kumar A, Pelorosso FG, DelRosario R, Huang EJ, Balmain A. Hipk2 cooperates with p53 to suppress γ-ray radiation-induced mouse thymic lymphoma. Oncogene. 31: 1176-80. PMID 21785465 DOI: 10.1038/onc.2011.306  0.281
2021 Chen WC, To MD, Westcott PMK, Delrosario R, Kim IJ, Philips M, Tran Q, Bollam SR, Goodarzi H, Bayani N, Mirzoeva O, Balmain A. Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells. Nature Communications. 12: 4288. PMID 34257283 DOI: 10.1038/s41467-021-24498-7  0.277
2023 Taylor MA, Kandyba E, Halliwill K, Delrosario R, Koroshkin M, Goodarzi H, Quigley D, Li YR, Wu D, Bollam S, Mirzoeva O, Akhurst RJ, Balmain A. Gene networks reveal stem-cell state convergence during preneoplasia and progression to malignancy in multistage skin carcinogenesis. Biorxiv : the Preprint Server For Biology. PMID 37215032 DOI: 10.1101/2023.05.08.539863  0.274
2004 Balmain A, Akhurst RJ. Cancer: dangerous liaisons. Nature. 428: 271-2. PMID 15029181 DOI: 10.1038/428271A  0.274
2005 Snijders AM, Nowak NJ, Huey B, Fridlyand J, Law S, Conroy J, Tokuyasu T, Demir K, Chiu R, Mao JH, Jain AN, Jones SJ, Balmain A, Pinkel D, Albertson DG. Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Research. 15: 302-11. PMID 15687294 DOI: 10.1101/Gr.2902505  0.266
1995 Cui W, Fowlis DJ, Cousins FM, Duffie E, Bryson S, Balmain A, Akhurst RJ. Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes & Development. 9: 945-55. PMID 7774812 DOI: 10.1101/Gad.9.8.945  0.266
2001 Anders M, Ding R, Lipner E, Balmain A, McCormick F, Korn W. Regulation of the coxsackie and adenovirus receptor (CAR) by the Ras/MAPK signal transduction pathway European Journal of Cancer. 37: S97. DOI: 10.1016/S0959-8049(01)80465-2  0.266
1979 Balmain A, Loehren D, Alonso A, Goerttler K. Protein synthesis during fetal development of mouse epidermis. II. Biosynthesis of histidine-rich and cystine-rich proteinsin vitro andin vivo Developmental Biology. 73: 338-344. PMID 499672 DOI: 10.1016/0012-1606(79)90071-X  0.265
1990 Balmain A, Brown K, Bremner R. The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis Immunology Series. 51: 75-88. PMID 2128916  0.265
2001 Nagase H, Mao JH, De Koning JP, Minami T, Balmain A. Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice Cancer Research. 61: 1305-1308. PMID 11245425  0.261
1995 Broome Powell M, Hyman P, Bell OD, Balmain A, Brown K, Alberts D, Bowden GT. Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 Ha-ras gene regulated by a mouse tyrosinase promoter Molecular Carcinogenesis. 12: 82-90. PMID 7662120 DOI: 10.1002/mc.2940120205  0.26
2021 Fores-Martos J, Cervera-Vidal R, Sierra-Roca J, Lozano-Asencio C, Fedele V, Cornelissen S, Edvarsen H, Tadeo-Cervera I, Eroles P, Lluch A, Tabares-Seisdedos R, Falcó A, Van't Veer LJ, Schmidt M, Quigley DA, ... ... Balmain A, et al. Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3 polymorphisms and gene co-expression. Npj Breast Cancer. 7: 118. PMID 34508103 DOI: 10.1038/s41523-021-00329-2  0.257
2020 Riva L, Pandiri AR, Li YR, Droop A, Hewinson J, Quail MA, Iyer V, Shepherd R, Herbert RA, Campbell PJ, Sills RC, Alexandrov LB, Balmain A, Adams DJ. The mutational signature profile of known and suspected human carcinogens in mice. Nature Genetics. PMID 32989322 DOI: 10.1038/s41588-020-0692-4  0.255
1989 Akhurst RJ, Lehnert SA, Fee F, Balmain A. The role of transforming growth factor-β in mouse development and carcinogenesis Biochemical Society Transactions. 17: 595-597. DOI: 10.1042/Bst0170595  0.255
2024 Swanton C, Bernard E, Abbosh C, André F, Auwerx J, Balmain A, Bar-Sagi D, Bernards R, Bullman S, DeGregori J, Elliott C, Erez A, Evan G, Febbraio MA, Hidalgo A, et al. Embracing cancer complexity: Hallmarks of systemic disease. Cell. 187: 1589-1616. PMID 38552609 DOI: 10.1016/j.cell.2024.02.009  0.253
1991 Burns PA, Brown K, Bremner R, Clarke M, Balmain A. Molecular alterations in oncogenes or tumor suppressor genes during chemical carcinogenesis Progress in Histochemistry and Cytochemistry. 23: 100-106. PMID 1947131 DOI: 10.1016/S0079-6336(11)80174-9  0.252
1982 Balmain A, Krumlauf R, Vass JK, Birnie GD. Cloning and characterisation of the abundant cytoplasmic 7S RNA from mouse cells Nucleic Acids Research. 10: 4259-4277. PMID 6896909 DOI: 10.1093/Nar/10.14.4259  0.25
1977 Balmain A, Loehren D, Fischer J, Alonso A. Protein synthesis during fetal development of mouse epidermis. I. The appearance of "histidine-rich protein" Developmental Biology. 60: 442-452. PMID 924021 DOI: 10.1016/0012-1606(77)90141-5  0.245
2000 Petritsch C, Beug H, Balmain A, Oft M. TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest Genes & Development. 14: 3093-3101. PMID 11124802 DOI: 10.1101/Gad.854200  0.244
1991 Burns PA, Jack A, Neilson F, Haddow S, Balmain A. Transformation of mouse skin endothelial cells in vivo by direct application of plasmid DNA encoding the human T24 H-ras oncogene. Oncogene. 6: 1973-8. PMID 1945407  0.243
1989 Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A, Goodwin GH. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures Experimental Cell Research. 184: 538-545. PMID 2806403 DOI: 10.1016/0014-4827(89)90352-2  0.243
1989 Bailleul B, Brown K, Ramsden M, Fee F, Balmain A. Initiation of skin carcinogenesis can occur by induction of carcinogen-specific point mutations in the Harvey-ras gene Progress in Clinical and Biological Research. 298: 137-145. PMID 2664807  0.243
1996 Nagase H, Bryson S, Fee F, Balmain A. Multigenic control of skin tumour development in mice. Ciba Foundation Symposium. 197: 156-68; discussion 1. PMID 8827373 DOI: 10.1002/9780470514887.CH9  0.242
1981 Balmain A, Sproul A, Birnie GD. Sequence divergence of nucleus-confined polyadenylated ribonucleic acids in friend erythroleukemic cells Biochemistry. 20: 6257-6264. PMID 6171299 DOI: 10.1021/Bi00524A054  0.24
1982 Ramsden M, Loehren D, Balmain A. Identification of a rapidly labelled 350K histidine-rich protein in neonatal mouse epidermis Differentiation. 23: 243-249. PMID 6406285 DOI: 10.1111/J.1432-0436.1982.Tb01289.X  0.234
1979 Balmain A, Birnie GD. Nick translation of mammalian DNA Bba Section Nucleic Acids and Protein Synthesis. 561: 155-166. PMID 570419 DOI: 10.1016/0005-2787(79)90499-4  0.232
1991 Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation. Oncogene. 6: 1465-70. PMID 1886717  0.227
2001 Papathoma AS, Zoumpourlis V, Balmain A, Pintzas A. Suppression of cell transformation and induction of apoptosis by caffeic acid phenethyl ester Molecular Carcinogenesis. 31: 83-89. PMID 11429785 DOI: 10.1002/mc.1043  0.224
1990 Parkinson K, Balmain A. Commentary: Chalones revisited-a possible role for transforming growth factor β in tumour promotion Carcinogenesis. 11: 195-198. PMID 2137380 DOI: 10.1093/Carcin/11.2.195  0.224
1982 Balmain A, Frew L, Cole G, Krumlauf R, Ritchie A, Birnie GD. Transcription of repeated sequences of the mouse B1 family in friend erythroleukaemic cells. Intermolecular RNA-RNA duplex formation between polyadenylated and non-polyadenylated nuclear RNAs Journal of Molecular Biology. 160: 163-179. PMID 6184479 DOI: 10.1016/0022-2836(82)90173-5  0.221
2015 Halliwill KD, Quigley D, Chin D, Le PT, Rosario RD, Balmain A. Abstract B1-21: Network analysis implicates Panx3 as an adipocyte associated factor important during carcinogenesis Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-B1-21  0.22
1988 Balmain A, Brown K, Akhurst RJ, Fee FM. Molecular analysis of chemical carcinogenesis in the skin British Journal of Cancer. 58: 72-75. PMID 3076069  0.21
1994 Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Research. 54: 1617-21. PMID 8137268  0.208
1991 Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A. Loss of growth control by TGF-β occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation. (Oncogene (1991) 6 (1465-1470)) Oncogene. 6: 2377-2378.  0.207
1977 Balmain A, Alonso A, Fischer J. Histone Phosphorylation and Synthesis of DNA and RNA during Phases of Proliferation and Differentiation Induced in Mouse Epidermis by the Tumor Promoter 12-0-T etradecanoyl-phorbol-13-acetate Cancer Research. 37: 1548-1555. PMID 851963  0.206
2001 Balmain A. Cancer genetics: from Boveri and Mendel to microarrays. Nature Reviews. Cancer. 1: 77-82. PMID 11900254 DOI: 10.1038/35094086  0.2
1994 Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Research. 54: 614-7. PMID 8306319  0.198
1981 Balmain A, Frew L, Ritchie A, Birnie GD. Intermolecular Rna-Rna Duplexes Between Polyadenylated And Non-Polyadenylat Ed Nuclear Rna From Friend Cells Biochemical Society Transactions. 9. DOI: 10.1042/Bst009173Pb  0.198
1998 Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, Balmain A. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 9: 393-404. PMID 9607560  0.186
2022 Balmain A. Peto's paradox revisited: black box vs mechanistic approaches to understanding the roles of mutations and promoting factors in cancer. European Journal of Epidemiology. PMID 36512199 DOI: 10.1007/s10654-022-00933-x  0.185
1996 Fowlis DJ, Cui W, Johnson SA, Balmain A, Akhurst RJ. Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor beta 1 in the skin of transgenic mice. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 7: 679-87. PMID 8732677  0.184
1989 Workman P, Balmain A, Hickman JA, McNally NJ, Rohas AM, Mitchison NA, Pierrepoint CG, Raymond R, Rowlatt C, Stephens TC, Wallace J, Straughan DW. UKCCCR Guidelines for the welfare of animals in experimental neoplasia Cancer and Metastasis Review. 8: 82-88. PMID 2758555 DOI: 10.1007/Bf00047059  0.181
1985 Balmain A, Quintanilla M, Brown K, Kerr IB, Ramsden M. Oncogenes and Cancer in Man and Animals Human &Amp; Experimental Toxicology. 4: 536. DOI: 10.1177/096032718500400515  0.176
2004 Ewart-Toland A, Chan JM, Yuan J, Balmain A, Ma J. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 759-64. PMID 15159307  0.174
1995 Bouffler SD, Kemp CJ, Balmain A, Cox R. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Research. 55: 3883-9. PMID 7641208  0.168
1996 MacCallum DE, Hupp TR, Midgley CA, Stuart D, Campbell SJ, Harper A, Walsh FS, Wright EG, Balmain A, Lane DP, Hall PA. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene. 13: 2575-87. PMID 9000131  0.16
2004 Dai Q, Cai QY, Shu XO, Ewart-Toland A, Wen WQ, Balmain A, Gao YT, Zheng W. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 2065-70. PMID 15598762  0.159
1992 Burns PA, Balmain A. Potential therapeutic targets in multistep oncogenesis Seminars in Cancer Biology. 3: 335-341. PMID 1286154  0.146
1976 Balmain A, Hecker E. On the biochemical mechanism of tumorigenesis in mouse skin. VII. The effects of tumor promoters on 3H-choline and 3H-glycerol incorporation into mouse epidermal phosphatidylcholine in relation to their effects on 3H-thymidine incorporation into DNA. Zeitschrift Fã¼R Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology. 86: 251-61. PMID 136100 DOI: 10.1007/BF00286944  0.136
1999 Frame S, Balmain A. Target genes and target cells in carcinogenesis British Journal of Cancer. 80: 28-33. PMID 10466758  0.127
2023 Balmain A. Air pollution's role in the promotion of lung cancer. Nature. 616: 35-36. PMID 37020001 DOI: 10.1038/d41586-023-00929-x  0.123
1997 Soder AI, Hoare SF, Muire S, Balmain A, Parkinson EK, Keith WN. Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting Genomics. 41: 293-294. PMID 9143511 DOI: 10.1006/geno.1997.4621  0.121
1978 Sauerborn R, Balmain A, Goerttler K, Stoehr M. On the existence of 'arrested G2 cells' in mouse epidermis Cell and Tissue Kinetics. 11: 291-300. PMID 657235  0.12
1998 Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J, Navaratnam V. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition) British Journal of Cancer. 77: 1-10. PMID 9459138  0.116
1992 Fowlis DJ, Flanders KC, Duffie E, Balmain A, Akhurst RJ. Discordant transforming growth factor beta 1 RNA and protein localization during chemical carcinogenesis of the skin Cell Growth &Amp; Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 3: 81-91. PMID 1504019  0.111
1998 Ganly I, Brown R, Balmain A. Infectivity and selective replication of an E1B deficient adenovirus in mouse cell lines British Journal of Cancer. 78: 155.  0.108
1989 Akhurst R, Bailleul B, Brown K, Ramsden M, Fee F, Balmain A. The action of oncogenes and growth factors in tumour initiation and promotion Carcinogenesis; a Comprehensive Survey. 11: 243-255. PMID 2493336  0.103
1974 Balmain A, Hecker E. Proceedings: The effects of tumour promotors on phospholipid metabolism in mouse epidermis. Hoppe-Seyler's Zeitschrift Fã¼R Physiologische Chemie. 355: 1171-2. PMID 4461462  0.093
1979 Aziz S, Balmain A, Knowler JT. Qualitative and quantitative changes in uterine mRNA populations in response to oestradiol treatment of rats European Journal of Biochemistry. 100: 95-100. PMID 488104 DOI: 10.1111/J.1432-1033.1979.Tb02037.X  0.073
1979 Brown TDK, Balmain A. The effects of mercury-substitution on the hybridisation characteristics of nucleic acids Nucleic Acids Research. 7: 2357-2368. PMID 392470 DOI: 10.1093/nar/7.8.2357  0.069
1980 Balmain A, Minty AJ, Birnie GD. Frequency distribution of pre-messenger RNA sequences in polyadenylated and non-polyadenylated nuclear RNA from friend cells Nucleic Acids Research. 8: 1643-1660. PMID 7433127 DOI: 10.1093/nar/8.7.1643  0.069
1967 Balmain A, Bjmer K, Connolly JD, Ferguson G. The constitution and stereochemistry of ε-caesalpin Tetrahedron Letters. 8: 5027-5031.  0.056
1981 Birnie GD, Balmain A, Jacobs H, Shott R, Wilkes PR, Paul J. Post-transcriptional control of messenger abundance Molecular Biology Reports. 7: 159-162. PMID 6114395 DOI: 10.1007/BF00778747  0.05
1970 Balmain A, Connolly JD, Ferrari M, Ghisalberti EL, Pagnoni UM, Pelizzoni F. The stereochemistry of the furanoditerpenoids α-, β-, and δ-caesalpin Journal of the Chemical Society D: Chemical Communications. 1244-1245. DOI: 10.1039/C29700001244  0.032
1975 Balmain A. Photochemical cleavage of the cyclopropane ring of 6,20-epoxylathyrol {1,11-diacetoxy-3,6,6,14-tetramethyl-13-phenylacetoxy(tricyclo-[10.3.0.0 <sup>5,7</sup>]pentadec-3-ene-10-spiro-2′-oxiran)-2-one} Journal of the Chemical Society, Perkin Transactions 2. 1253-1256. DOI: 10.1039/P29750001253  0.028
1988 Workman P, Balmain A, Hickman JA, McNally NJ, Rohas AM, Mitchison NA, Pierrepoint CG, Raymond R, Rowlatt C, Stephens TC. UKCCCR guidelines for the welfare of animals in experimental neoplasia. Laboratory Animals. 22: 195-201. PMID 3172698  0.027
1973 Balmain A, Connolly JD. Minor diterpenoid constituents of Andrographis panicdata nees Journal of the Chemical Society, Perkin Transactions 1. 1247-1251. DOI: 10.1039/P19730001247  0.023
1926 Balmain AR. AN INVESTIGATION INTO THE ÆTIOLOGY OF IMPETIGO CONTAGIOSA (56 CASES) WITH NOTES ON TREATMENT (263 CASES) The Lancet. 208: 484-487.  0.023
1929 Burton AHG, Balmain AR. FOREIGN BODIES AND NASAL CARRIERS OF DIPHTHERIA The Lancet. 214: 977-978.  0.023
1979 Aziz S, Balmain A, Knowler JT. Diveristy and complexity of uterine mRNA from rats of differing hormonal states European Journal of Biochemistry. 100: 85-94.  0.02
1929 Burton AHG, Balmain AR. SCARLET FEVER. SOME ASPECTS OF BACTERIOLOGY AND SERUM TREATMENT The Lancet. 214: 545-550.  0.016
1971 Balmain A, Ourisson G. Photochemistry of the extended conjugated system 3-oxoprop-1- enylcyclopropane of the diterpene, epoxylathyrol Journal of the Chemical Society D: Chemical Communications. 268b-270. DOI: 10.1039/C2971000268b  0.014
1930 Burton AHG, Balmain AR. VITAMIN A AND STREPTOCOCCAL ANTITOXIC IMMUNITY The Lancet. 215: 1063-1066.  0.012
2004 Chapman S, Balmain A. Time to legislate for fire-safe cigarettes in Australia Medical Journal of Australia. 181: 292-293. PMID 15377234  0.01
2004 Balmain A, Akhurst RJ. X-ray eyes on Saturn Nature. 428: 272. DOI: 10.1038/428272a  0.01
1989 Balmain A. Working hypothesis Molecular Carcinogenesis. 2: 303-304.  0.01
1970 Adolf W, Hecker E, Balmain A, Lhomme MF, Nakatani Y, Ourisson G, Ponsinet G, Pryce RJ, Santhanakrishnan TS, Matyukhina LG, Saltikova IA. "Euphorbiasteroid" (Epoxy-lathyrol) A new tricyclic diterpene from Euphorbia lathyris L Tetrahedron Letters. 11: 2241-2244. DOI: 10.1016/S0040-4039(01)98198-5  0.01
1931 Burton AHG, Balmain AR. DIPHTHERIA IMMUNITY AND TONSILLECTOMY The Lancet. 218: 1401-1403.  0.01
1931 Burton AHG, Balmain AR. RECOVERY FROM STREPTOCOCCAL SEPTICÆMIA. COMPLICATED BY BRONCHO-PNEUMONIA AND PERICARDITIS The Lancet. 218: 72-74.  0.01
1929 Balmain AR. The dick test in scarlet fever._ British Medical Journal. 1: 477. DOI: 10.1136/bmj.1.3557.477-c  0.01
1928 Burton AHG, Balmain AR. RELAPSES IN SCARLET FEVER The Lancet. 211: 1060-1063.  0.01
1928 Burton AHG, Balmain AR. A SEVERE "RELAPSE" IN A CASE OF DIPHTHERIA The Lancet. 212: 1182-1183.  0.01
1927 Balmain AR. RECOVERY OF STREPTOCOCCUS SCARLATINÆ FROM EXPERIMENTALLY INFECTED BOOKS The Lancet. 210: 1128.  0.01
Hide low-probability matches.